Serrano Maria F, Katz Matthew, Yan Yan, Kibel Adam S, Humphrey Peter A
Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.
The prognostic value of Fuhrman nuclear grade for patients with renal cell carcinoma has been well-characterized. However, to the authors' knowledge, the prognostic significance of the amount of high-grade renal cell carcinoma has not been previously analyzed.
The authors identified 898 consecutive renal cell carcinoma cases treated with nephrectomy between 1989 and 2003. Histopathologic features that were captured based on re-review of all slides included histologic type, pathologic stage, conventional Fuhrman grade, and percentage of Fuhrman grade 3 and 4 carcinoma, as ascertained by visual inspection of histologic slides. The clinical endpoints were metastasis-free survival, cancer-specific survival, and overall survival.
Kaplan-Meier analysis demonstrated that both conventional Fuhrman grading and the percentage of Fuhrman grade 3 and 4 carcinoma were highly correlated with all 3 measures of patient survival (P < .0001). The creation of 3 categories of the percentage of Fuhrman grade 3 and 4 carcinoma (0%, 1-50%, and 51-100%) generated distinctly separate survival curves. On Cox proportional hazards multivariate analysis, TNM stage, tumor size, and the percentage of Fuhrman grade 3 and 4 carcinoma were all found to be significantly associated with all 3 types of patient survival (all P values <.05).
The determination of the percentage of renal cell carcinoma that is 0%, 1% to 50%, or 51% to 100% high Fuhrman grade 3 and 4 is a simple and powerful measurement of patient outcome after surgery that provides additional prognostic information beyond stage, tumor size, and conventional Fuhrman grade. This prognostic information could be useful in the stratification of patients into prognostic groups for the development of more individualized follow-upschedules and for enrollment into clinical trials.
福尔曼核分级对肾细胞癌患者的预后价值已得到充分阐明。然而,据作者所知,高级别肾细胞癌数量的预后意义此前尚未得到分析。
作者确定了1989年至2003年间连续接受肾切除术治疗的898例肾细胞癌病例。通过重新审查所有切片获得的组织病理学特征包括组织学类型、病理分期、传统福尔曼分级以及福尔曼3级和4级癌的百分比,通过对组织学切片的目视检查确定。临床终点为无转移生存期、癌症特异性生存期和总生存期。
Kaplan-Meier分析表明,传统福尔曼分级以及福尔曼3级和4级癌的百分比与患者生存的所有3项指标均高度相关(P <.0001)。将福尔曼3级和4级癌的百分比分为3类(0%、1 - 50%和51 - 100%)产生了明显分开的生存曲线。在Cox比例风险多变量分析中,TNM分期、肿瘤大小以及福尔曼3级和4级癌的百分比均与所有3种类型的患者生存显著相关(所有P值<.05)。
确定肾细胞癌中福尔曼3级和4级高分级为0%、1%至50%或51%至100%的百分比是一种简单而有效的术后患者预后测量方法,它提供了超出分期、肿瘤大小和传统福尔曼分级的额外预后信息。这种预后信息可用于将患者分层到预后组,以制定更个性化的随访计划并纳入临床试验。